Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardica, Cook Join Race To Enter PFO Closure Market

This article was originally published in The Gray Sheet

Executive Summary

Cardica and Cook Medical are teaming up to develop a patent foramen ovale (PFO) closure device, joining a growing list of firms trying to enter this market. The companies announced the partnership June 19

You may also be interested in...



Study Establishes Link Between PFO And Cryptogenic Stroke In Older Patients

A new study shows a correlation between patent foramen ovale (PFO) and cryptogenic strokes in older patients

Study Establishes Link Between PFO And Cryptogenic Stroke In Older Patients

A new study shows a correlation between patent foramen ovale (PFO) and cryptogenic strokes in older patients

Firms Say Randomized Controlled Trials For PFO Closure Devices Reasonable

NMT Medical and AGA Medical say they are ready to follow an FDA advisory panel's recommendations for premarket trials of PFO closure devices for the treatment of cryptogenic stroke

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel